Browse > Article
http://dx.doi.org/10.3345/kjp.2009.52.4.429

Clinical findings of severe amniotic fluid aspiration pneumonia and effects of surfactant replacement therapy  

Park, Sang Woo (Department of Pediatrics, Keimyung University School of Medicine)
Kim, Chun-Soo (Department of Pediatrics, Keimyung University School of Medicine)
Lee, Sang-Lak (Department of Pediatrics, Keimyung University School of Medicine)
Kwon, Tae-Chan (Department of Pediatrics, Keimyung University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.52, no.4, 2009 , pp. 429-434 More about this Journal
Abstract
Purpose : Severe aspiration of the amniotic fluid is known to cause fatal respiratory distress in neonates. We conducted this study to investigate the clinical findings of severe amniotic fluid aspiration pneumonia (AFAP) in neonates and the effect of pulmonary surfactant replacement therapy (SRT). Methods : Retrospective analysis of medical records was conducted on 28 patients who received ventilator care due to severe AFAP in a neonatal intensive care unit over a 7-year period (2000-2006). Patients whose amniotic fluid was contaminated with meconium were excluded. Results : A large number of cases were term infants (82.1%) and infants born by caesarean section (85.7%), and the 1- and 5-min Apgar scores of these patients were $6.5{\pm}1.2$ and $7.5{\pm}1.3$, respectively. Soon after birth, the amount of amniotic fluid sucked out from airway below the vocal cord was $16.0{\pm}10.1$ mL. All patients received SRT with a modified bovine-derived surfactant (120 mg/kg/dose), and one dose was administered in most cases (75%). Compared with pre-SRT, the oxygenation index ($8.0{\pm}9.6$ vs. $18.9{\pm}7.3$) according to ventilator care was a significant improvement at 12 h after SRT (P<0.001). Furthermore, most cases showed radiological improvement for aeration at 12 h post-treatment. Many cases (46.4%) had cardiorespiratory complications, but their final outcomes were excellent (survival rate, 96.4%). Conclusion : AFAP may be an important cause of serious respiratory distress in near-term and term infants, and SRT seems to be an effective adjuvant therapy in mechanically ventilated neonates with severe AFAP.
Keywords
Amniotic Fluid; Aspiration Pneumonia; Pulmonary Surfactant;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Enzman Hagedorn MI, Gardner SL, Dickey LA, Abman SH. Respiratory diseases. In : Merenstein GB, Gardner SL. editors. Handbook of neonatal intensive care. 6th ed. Philadelphia : Elsevier Inc, 2006:596-698
2 Bouziri A, Ben Slima S, Hamdi A, Menif K, Belhadj S, Khaldi A, et al. Acute respiratory distress syndrome in infants at term and near term about 23 cases. Tunis Med 2007;85:874-9   PUBMED
3 Lacaze-Masmonteil T. Surfactant replacement therapy. In : Donn SM, Sinha SK, editors. Mannual of neonatal resporatory care. 2nd ed. Philadelphia : Elsevier Inc, 2006:396-401
4 Shon SM, Lee BY, Kim CS, Lee SL, Kwon TC. The outcome of surfactant replacement therapy in above nearterm neonates with severe pulmonary disease. Korean J Pediatr 2007;50: 1200-5   DOI   ScienceOn
5 Choi CW, Kim BI, Joung KE, Lee HJ, Joung KE, Shim KH, et al. Clinical characteristics of severe meconium aspiration syndrome. Korean J Pediatr 2008;51:713-21   DOI   ScienceOn
6 Pfenninger J, Tschaeppeler H, Wagner BP, Weber J, Zimmerman A. The paradox of adult respiratory distress syndrome in neonates. Pediatr Pulmonol 991;10:18-24   DOI   ScienceOn
7 Bolisetty S, Patole SK, McBride GA, Whitehall JS. Neonatal amniotic fluid aspiration syndrome underdiagnosed? Int J Clin Pract 2001;55:727-8   PUBMED   ScienceOn
8 Karetzky M, Ramirez M. Acute respiratory failure in pregnancy. An analysis of 19 cases. Medicine (Baltimore) 1998; 77:41-9   DOI   ScienceOn
9 Nagase T, Ishii S, Kume K, Uozumi N, Izumi T, Ouchi Y, et al. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J Clin Invest 1999; 104:1071-6   DOI   PUBMED   ScienceOn
10 Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980;1:55-9   DOI   PUBMED   ScienceOn
11 Stevens TP, Sinkin RA. Surfactant replacement therapy. Chest 2007;131:1577-82   DOI   ScienceOn
12 Heritage CK, Cunningham MD. Association of elective repeat cesarean delivery and persistent pulmonary hypertension of the newborn. Am J Obstet Gynecol 1985;152:627-9   PUBMED
13 Faix RG, Viscardi RM, DiPietro MA, Nicks JJ. Adult respiratory distress syndrome in full-term newborns. Pediatrics 1989;83:971-6   PUBMED   ScienceOn
14 Miller MJ, Fanaroff AA, Martin RJ. Respiratory disease in preterm and term infants. In:Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine. 7th ed. St Louis: Mosby, 2002:1025-49
15 Kim JJ, Cho YJ, Park GS, Kim MS, Lee SL, Kim JS, et al. A Case of Acute Respiratory Distress Syndrome Occurred after Pulmonary Edema in a Fullterm Newborn. J Korean Soc Neonatol 2000;7:54-8
16 Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24   PUBMED   ScienceOn
17 Chima RS, Zingarelli B. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Crit Care Med 2007;35:2442-3   DOI   ScienceOn
18 Marraro GA, Luchetti M, Galassini EM, Abbiati G. Natural surfactant supplementation in ARDS in paediatric age. Minerva Anestesiol 1999;65:92-7   PUBMED   ScienceOn
19 Ohlsson A, Cumming WA, Najjar H. Neonatal aspiration syndrome due to vernix caseosa. Pediatr Radiol 1985;15: 193-5   DOI   ScienceOn
20 Cunningham FG, Hauth JC, Leveno KJ, Gilstrap III L, Bloom SL, Wenstrom KD. Williams obstetrics. 22nd ed. New York : McGraw-Hill, 2005:91-120
21 Nishijima K, Shukunami K, Inoue S, Kotsuji F. Management for neonatal aspiration syndrome caused by vernix caseosa. Fetal Diagn Ther 2005;20:194-6   DOI   ScienceOn
22 Taeusch HW, Ramierez-Schrempp D, Laing IA. Surfactant therapy of respiratory disorders. In : Taeusch HW, Ballard RA, Gleason CA. editors. Avery's diseases of the newborn. 8th ed. Philadelphia : Elsevier Inc, 2005:670-85
23 Wolf RB, Moore TR. Amniotic fluid and nonimmune hydrops fetalis. In : Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine. 7th ed. St Louis : Mosby, 2002:351-70
24 Kim CH, Lee MY, Park HM, Kim WK, Bae DH. Histopathological study of aspiration pneumonia by human amniotic fluid in rabbits. Korean J Obstet Gynecol 1990;33:907-16
25 Xu W, Xia SH, Wang H, Chen H, Wang YL. Role of platelet activating factor in pathogenesis of acute respiratory distress syndrome. Chin Med J 2007;120:1840-4   PUBMED   ScienceOn
26 Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293:470-6   DOI   ScienceOn
27 Jose JH. Schreiner RL. Lemons JA. Gresham EL. Mirkin LD. Siddiqui A, et al. The effect of amniotic fluid aspiration on pulmonary function in the adult and newborn rabbit. Pediatr Res 1983;17:976-81   PUBMED   ScienceOn
28 Herting E, Mller O, Schiffmann JH, Robertson B. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr 2002;91:1174-8   DOI   ScienceOn
29 Ikeda N. Yamakawa M. Imai Y. Suzuki T. Sudden infant death from atelectasis due to amniotic fluid aspiration. Am J Forensic Med Pathol 1989;10:340-3   DOI
30 Choi BY, Kim KM, Yoon JS, Lee JS. A case of acute respiratory distress syndrome treated with surfactant and low dose methylprednisolone. Korean J Pediatr 2006;49:455-9   DOI
31 Bae CW, Kim YM. Surfactant therapy for neonatal respiratory distress syndrome: experience in Korea over 15 years. Korean J Pediatr 2004;47:940-8
32 Braquet P, Hosford D. The potential role of platelet-activating factor in shock and ischemia. J Crit Care 1990;5:115-36   DOI   ScienceOn
33 Greenough A, Roberton NRC. Acute respiratory disease in the newborn. In : Rennie JM, Roberton NRC, editors. Textbook of neonatology. 3rd ed. London : Churchill Livingstone, 2000:481-607
34 Ko JM, Ha EJ, Lee EH, Lee SY, Kim HB, Hong SJ, et al. Clinical Outcome and Prognostic Factors of Acute Respiratory Distress Syndrome in Children.Korean J Pediatr 2005; 48:599-605
35 Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959; 97:517-23
36 Schwarz A. Acute respiratory distress syndrome. In : Czervinske MP, Barnhart SL. editors. Perinatal and pediatric respiratory care. 2nd ed. Philadelphia : Saunders, 2003:604-9